nodes	percent_of_prediction	percent_of_DWPC	metapath
Lacosamide—SCN3A—spinal nerve—leprosy	0.105	0.242	CbGeAlD
Lacosamide—Inner ear disorder—Thalidomide—leprosy	0.0645	0.114	CcSEcCtD
Lacosamide—Labyrinthine disorder—Thalidomide—leprosy	0.0645	0.114	CcSEcCtD
Lacosamide—CA6—ear—leprosy	0.0547	0.127	CbGeAlD
Lacosamide—CA3—ear—leprosy	0.0518	0.12	CbGeAlD
Lacosamide—SCN10A—peripheral nervous system—leprosy	0.0283	0.0657	CbGeAlD
Lacosamide—Suicide attempt—Dapsone—leprosy	0.0279	0.049	CcSEcCtD
Lacosamide—SCN10A—nerve—leprosy	0.0221	0.0512	CbGeAlD
Lacosamide—CA1—nerve—leprosy	0.0183	0.0424	CbGeAlD
Lacosamide—Proteinuria—Dapsone—leprosy	0.018	0.0317	CcSEcCtD
Lacosamide—Protein urine present—Dapsone—leprosy	0.0177	0.0312	CcSEcCtD
Lacosamide—Paraesthesia oral—Thalidomide—leprosy	0.0173	0.0304	CcSEcCtD
Lacosamide—CA4—nerve—leprosy	0.0143	0.0331	CbGeAlD
Lacosamide—Suicide attempt—Thalidomide—leprosy	0.0143	0.0251	CcSEcCtD
Lacosamide—Nystagmus—Thalidomide—leprosy	0.0113	0.0199	CcSEcCtD
Lacosamide—Psychotic disorder—Dapsone—leprosy	0.0112	0.0197	CcSEcCtD
Lacosamide—Blood disorder—Thalidomide—leprosy	0.00969	0.017	CcSEcCtD
Lacosamide—Proteinuria—Thalidomide—leprosy	0.00921	0.0162	CcSEcCtD
Lacosamide—Protein urine present—Thalidomide—leprosy	0.00908	0.016	CcSEcCtD
Lacosamide—CA3—tendon—leprosy	0.00903	0.0209	CbGeAlD
Lacosamide—CA9—tendon—leprosy	0.00864	0.02	CbGeAlD
Lacosamide—Atrioventricular block—Thalidomide—leprosy	0.00834	0.0147	CcSEcCtD
Lacosamide—Gait disturbance—Thalidomide—leprosy	0.00829	0.0146	CcSEcCtD
Lacosamide—Coordination abnormal—Thalidomide—leprosy	0.00824	0.0145	CcSEcCtD
Lacosamide—CA14—tendon—leprosy	0.0082	0.019	CbGeAlD
Lacosamide—SCN9A—tendon—leprosy	0.00803	0.0186	CbGeAlD
Lacosamide—CA1—eye—leprosy	0.00765	0.0177	CbGeAlD
Lacosamide—CA3—testis—leprosy	0.00748	0.0173	CbGeAlD
Lacosamide—Tinnitus—Dapsone—leprosy	0.0074	0.013	CcSEcCtD
Lacosamide—CA3—nervous system—leprosy	0.00734	0.017	CbGeAlD
Lacosamide—CA9—testis—leprosy	0.00716	0.0166	CbGeAlD
Lacosamide—Euphoric mood—Thalidomide—leprosy	0.00695	0.0122	CcSEcCtD
Lacosamide—Erythema—Dapsone—leprosy	0.00691	0.0122	CcSEcCtD
Lacosamide—SCN9A—testis—leprosy	0.00665	0.0154	CbGeAlD
Lacosamide—Vision blurred—Dapsone—leprosy	0.00651	0.0115	CcSEcCtD
Lacosamide—Vertigo—Dapsone—leprosy	0.00621	0.0109	CcSEcCtD
Lacosamide—Atrial fibrillation—Thalidomide—leprosy	0.0062	0.0109	CcSEcCtD
Lacosamide—Osteoarthritis—Thalidomide—leprosy	0.00587	0.0103	CcSEcCtD
Lacosamide—Diplopia—Thalidomide—leprosy	0.00587	0.0103	CcSEcCtD
Lacosamide—Affect lability—Thalidomide—leprosy	0.00578	0.0102	CcSEcCtD
Lacosamide—Psychotic disorder—Thalidomide—leprosy	0.00574	0.0101	CcSEcCtD
Lacosamide—CA5B—tendon—leprosy	0.00574	0.0133	CbGeAlD
Lacosamide—SCN3A—tendon—leprosy	0.00557	0.0129	CbGeAlD
Lacosamide—Mood swings—Thalidomide—leprosy	0.00556	0.00979	CcSEcCtD
Lacosamide—Ataxia—Thalidomide—leprosy	0.00552	0.00972	CcSEcCtD
Lacosamide—Liver function test abnormal—Thalidomide—leprosy	0.00542	0.00954	CcSEcCtD
Lacosamide—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00529	0.00931	CcSEcCtD
Lacosamide—Insomnia—Dapsone—leprosy	0.0051	0.00898	CcSEcCtD
Lacosamide—Eosinophilia—Thalidomide—leprosy	0.00503	0.00884	CcSEcCtD
Lacosamide—SCN10A—nervous system—leprosy	0.00497	0.0115	CbGeAlD
Lacosamide—CA2—eye—leprosy	0.00496	0.0115	CbGeAlD
Lacosamide—CA5B—testis—leprosy	0.00475	0.011	CbGeAlD
Lacosamide—Neutropenia—Thalidomide—leprosy	0.00475	0.00835	CcSEcCtD
Lacosamide—CA5B—nervous system—leprosy	0.00466	0.0108	CbGeAlD
Lacosamide—SCN3A—testis—leprosy	0.00462	0.0107	CbGeAlD
Lacosamide—SCN3A—nervous system—leprosy	0.00453	0.0105	CbGeAlD
Lacosamide—Depression—Thalidomide—leprosy	0.00451	0.00794	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00449	0.0079	CcSEcCtD
Lacosamide—Body temperature increased—Dapsone—leprosy	0.00446	0.00784	CcSEcCtD
Lacosamide—CA2—skin of body—leprosy	0.00431	0.00999	CbGeAlD
Lacosamide—Agranulocytosis—Thalidomide—leprosy	0.00422	0.00743	CcSEcCtD
Lacosamide—Bradycardia—Thalidomide—leprosy	0.00414	0.00728	CcSEcCtD
Lacosamide—CA1—nervous system—leprosy	0.00412	0.00953	CbGeAlD
Lacosamide—Hepatitis—Thalidomide—leprosy	0.00406	0.00715	CcSEcCtD
Lacosamide—Hypoaesthesia—Thalidomide—leprosy	0.00404	0.00711	CcSEcCtD
Lacosamide—CA4—tendon—leprosy	0.00396	0.00917	CbGeAlD
Lacosamide—Erythema multiforme—Thalidomide—leprosy	0.00384	0.00676	CcSEcCtD
Lacosamide—Eye disorder—Thalidomide—leprosy	0.0038	0.00668	CcSEcCtD
Lacosamide—Tinnitus—Thalidomide—leprosy	0.00379	0.00667	CcSEcCtD
Lacosamide—Cardiac disorder—Thalidomide—leprosy	0.00377	0.00664	CcSEcCtD
Lacosamide—Immune system disorder—Thalidomide—leprosy	0.00367	0.00646	CcSEcCtD
Lacosamide—Vomiting—Dapsone—leprosy	0.00359	0.00631	CcSEcCtD
Lacosamide—Mental disorder—Thalidomide—leprosy	0.00356	0.00626	CcSEcCtD
Lacosamide—Headache—Dapsone—leprosy	0.00353	0.00622	CcSEcCtD
Lacosamide—Flatulence—Thalidomide—leprosy	0.00349	0.00613	CcSEcCtD
Lacosamide—Muscle spasms—Thalidomide—leprosy	0.0034	0.00598	CcSEcCtD
Lacosamide—Nausea—Dapsone—leprosy	0.00335	0.00589	CcSEcCtD
Lacosamide—Vision blurred—Thalidomide—leprosy	0.00333	0.00587	CcSEcCtD
Lacosamide—Tremor—Thalidomide—leprosy	0.00331	0.00583	CcSEcCtD
Lacosamide—CA2—tendon—leprosy	0.00328	0.0076	CbGeAlD
Lacosamide—CA4—testis—leprosy	0.00328	0.00759	CbGeAlD
Lacosamide—Anaemia—Thalidomide—leprosy	0.00327	0.00575	CcSEcCtD
Lacosamide—Agitation—Thalidomide—leprosy	0.00325	0.00572	CcSEcCtD
Lacosamide—Angioedema—Thalidomide—leprosy	0.00323	0.00569	CcSEcCtD
Lacosamide—CA4—nervous system—leprosy	0.00322	0.00745	CbGeAlD
Lacosamide—Vertigo—Thalidomide—leprosy	0.00318	0.00559	CcSEcCtD
Lacosamide—Syncope—Thalidomide—leprosy	0.00317	0.00558	CcSEcCtD
Lacosamide—Palpitations—Thalidomide—leprosy	0.00313	0.0055	CcSEcCtD
Lacosamide—Loss of consciousness—Thalidomide—leprosy	0.00311	0.00547	CcSEcCtD
Lacosamide—Chest pain—Thalidomide—leprosy	0.00301	0.0053	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00299	0.00526	CcSEcCtD
Lacosamide—Discomfort—Thalidomide—leprosy	0.00298	0.00524	CcSEcCtD
Lacosamide—Dry mouth—Thalidomide—leprosy	0.00294	0.00518	CcSEcCtD
Lacosamide—Confusional state—Thalidomide—leprosy	0.00291	0.00512	CcSEcCtD
Lacosamide—Shock—Thalidomide—leprosy	0.00284	0.005	CcSEcCtD
Lacosamide—Nervous system disorder—Thalidomide—leprosy	0.00283	0.00498	CcSEcCtD
Lacosamide—Skin disorder—Thalidomide—leprosy	0.0028	0.00493	CcSEcCtD
Lacosamide—Hyperhidrosis—Thalidomide—leprosy	0.00279	0.00491	CcSEcCtD
Lacosamide—CA2—testis—leprosy	0.00272	0.0063	CbGeAlD
Lacosamide—CA2—nervous system—leprosy	0.00267	0.00618	CbGeAlD
Lacosamide—Insomnia—Thalidomide—leprosy	0.00261	0.00459	CcSEcCtD
Lacosamide—Paraesthesia—Thalidomide—leprosy	0.00259	0.00456	CcSEcCtD
Lacosamide—Somnolence—Thalidomide—leprosy	0.00257	0.00452	CcSEcCtD
Lacosamide—Dyspepsia—Thalidomide—leprosy	0.00254	0.00447	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Thalidomide—leprosy	0.00249	0.00439	CcSEcCtD
Lacosamide—Fatigue—Thalidomide—leprosy	0.00249	0.00438	CcSEcCtD
Lacosamide—Constipation—Thalidomide—leprosy	0.00247	0.00434	CcSEcCtD
Lacosamide—Feeling abnormal—Thalidomide—leprosy	0.00238	0.00419	CcSEcCtD
Lacosamide—Urticaria—Thalidomide—leprosy	0.00229	0.00404	CcSEcCtD
Lacosamide—Body temperature increased—Thalidomide—leprosy	0.00228	0.00402	CcSEcCtD
Lacosamide—Hypersensitivity—Thalidomide—leprosy	0.00213	0.00374	CcSEcCtD
Lacosamide—Asthenia—Thalidomide—leprosy	0.00207	0.00364	CcSEcCtD
Lacosamide—Pruritus—Thalidomide—leprosy	0.00204	0.00359	CcSEcCtD
Lacosamide—Diarrhoea—Thalidomide—leprosy	0.00198	0.00348	CcSEcCtD
Lacosamide—Dizziness—Thalidomide—leprosy	0.00191	0.00336	CcSEcCtD
Lacosamide—Vomiting—Thalidomide—leprosy	0.00184	0.00323	CcSEcCtD
Lacosamide—Rash—Thalidomide—leprosy	0.00182	0.0032	CcSEcCtD
Lacosamide—Dermatitis—Thalidomide—leprosy	0.00182	0.0032	CcSEcCtD
Lacosamide—Headache—Thalidomide—leprosy	0.00181	0.00318	CcSEcCtD
Lacosamide—Nausea—Thalidomide—leprosy	0.00171	0.00302	CcSEcCtD
